insulin analog

(redirected from Insulin analogue)

insulin analog

A synthetic insulin in which small changes in the amino acid structure of the polypeptide result in changes in the onset, peak effect, or duration of the molecule's physiological effects. Insulin aspart, glargine, and lispro are all insulin analogues.
See also: analogue
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
The latter formulations combine a fixed combination of short-acting regular insulin or rapid-acting insulin analogue with an intermediate-acting protamine component providing mealtime and basal blood glucose control in one injection, which offers a more convenient however less flexible form of treatment in terms of titration and timing and requires a regulated lifestyle [1, 7].
Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir.
Of these, five were excluded that did not cover some type of insulin analogue. 58 were outside of the period from 2010 to 2013 and two had defendants who were not from Sesab.
Insulin is available as human insulin and its modified version insulin analogue. Insulin analogue is ten times more expensive than human insulin and has no worth-while advantages.
The Food and Drug Administration has declined to approve insulin degludec, calling for more cardiovascular safety data on the long-acting basal insulin analogue, setting back the timeline for its availability by at least a year.
The label update makes Levemir the first and only basal insulin analogue approved for use in patients as young as 2.
Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes.
Washington, June 27 (ANI): Diabetes patients' risk of cancer increases if they use the long-acting insulin analogue glargine instead of human insulin, according to a study.
The new research was released after mounting speculation that damaging data was about to be published over a cancer link with Sanofis modern long-acting insulin analogue, sinking the French drugmakers share price by 12.3 percent in two days,ARY News reported.
Insuline Detemir is a soluble basal insulin analogue indicated for the basic insulin therapy in both type 1 and 2 diabetes.